Theo Meyer to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Theo Meyer has written about Adrenergic beta-Antagonists.
Connection Strength
0.713
-
Goldberg RJ, Spencer FA, Farmer C, Lessard D, Pezzella SM, Meyer TE. Use of disease-modifying therapies in patients hospitalized with heart failure: a population-based perspective. Am J Med. 2007 Jan; 120(1):98.e1-8.
Score: 0.254
-
Meyer TE. The carvedilol or metoprolol European trial. Curr Cardiol Rep. 2004 May; 6(3):198-9.
Score: 0.211
-
Perlini S, Khoury EP, Norton GR, Chung ES, Fenton RA, Dobson JG, Meyer TE. Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. Circ Res. 1998 Oct 05; 83(7):761-71.
Score: 0.143
-
Spencer FA, Meyer T. Heart failure and shock complicating acute coronary syndromes. Curr Cardiol Rep. 2005 Jul; 7(4):276-82.
Score: 0.057
-
Seth PS, Aurigemma GP, Krasnow JM, Tighe DA, Untereker WJ, Meyer TE. A syndrome of transient left ventricular apical wall motion abnormality in the absence of coronary disease: a perspective from the United States. Cardiology. 2003; 100(2):61-6.
Score: 0.048